French pharmaceutical company said drug could treat COVID-19 patients after promising test results
A leading French pharmaceutical company said it could potentially treat 300,000 COVID-19 patients with the anti-malarial drug Plaquenil after what it described as “promising” test results.
Sanofi said it was ready to offer France millions of doses of Plaquenil, a spokesperson for the laboratory told AFP, adding that the group was ready to work with French health authorities “to confirm these results.”
The study on 24 patients with coronavirus using Plaquenil, a hydroxychloroquine molecule, which has also been used for decades for the treatment of autoimmune diseases like lupus or rheumatoid arthritis.
Six days after the start of taking Plaquenil, the virus had disappeared in three-quarters of those treated, said Professor Didier Raoult, who is director of the Institut Hospitalo-Universitaire de Marseille.
The French government said the clinical trials were “promising” and would be extended to more patients.
You may be interested
Coronavirus Greece: 1,269 new cases, 379 intubated, 36 deathsPanos - Mar 01, 2021
The Greek authorities announced today the new laboratory-confirmed cases of the coronavirus that were recorded in the last 24 hours…
BBC: The last speakers of Ancient SpartaPanos - Feb 26, 2021
As you enter the mountainous village of Pera Melana in Greece’s southern Peloponnese peninsula, you’re likely to hear the roar of…
Coronavirus Greece: 1,784 new cases, 367 intubated, 39 deathsPanos - Feb 26, 2021
Greece announced today that the new laboratory confirmed cases of the disease recorded in the last 24 hours are 1,784, of…